Biology for Engineers (BIT1001)

Module IV
TRENDS IN BIOENGINEERING
Definition: Bioengineering integrates principles from biology, engineering, and technology to
solve problems in medicine, healthcare, agriculture, and the environment. Enables development
of innovative diagnostics, therapies, and sustainable solutions.

Bioprinting Techniques and Materials

Bioprinting is a rapidly growing field that uses various techniques to produce three-dimensional
(3D) structures and functional biological tissues for medical and scientific applications. The
main objective of bioprinting is to mimic the structure and function of tissues and organs,
leading to the development of replacements for damaged or diseased organs.

Figure: Schematic representation of the 3D bioprinting process.

Table. Comparison between a 3D printer and a bioprinter

Aspect 3D Printers Bioprinters
Printing
General-purpose printing of objects Fabrication of living tissues and organs
Purpose
Bioinks (hydrogels, extracellular matrices,
Materials Plastics, metals, ceramics, resins, etc.
cell aggregates, etc.)
Manufacturing, engineering, product Regenerative medicine, tissue engineering,
Applications
design, architecture, etc. drug development, etc.
Additive manufacturing, layer-by-
Printing Process Precise deposition of bio-ink layer-by-layer
layer deposition
Cell Bioinks must support cell viability and
N/A
Compatibility function
 Development of suitable bioinks, cell
Challenges N/A
viability, vascularization, scaling up, etc.

• Potential for tissue and organ

transplantation.
Versatile, wide range of applications.• Enables tissue engineering and
Advantages Enables rapid prototyping cost- regenerative medicine.
effective for non-biological objects • Can create tissue models for studying diseases.
• Potential for personalized medicine and drug
testing
Complex and rapidly evolving technology
Limited ability to create functional
Challenges in developing suitable bioinks and
living tissues, limited choice of
scaling up.
materials for certain applications and
Vascularization and long-term functionality of
Limitations lack of cell compatibility and tissue.
printed tissues.
Note: Cell viability refers to the ability of cells to remain alive and maintain their normal
cellular functions. Vascularization refers to the process of creating functional blood vessel
networks within bio-printed tissues or organs.

Bioinks
Bioinks are biological materials used in the manufacture of engineered live tissues through the
process of 3D bioprinting. Bioink refers to the cells used in manufacturing and the carrier
molecules that support the growth of these cells. Common carrier materials used with cells
during bioprinting are biopolymer gels that act as a 3D molecular scaffold so that cells can
attach, grow, and increase. The biopolymers used in bioink are essential as they retain water,
providing mechanical stability to the engineered tissues. The selection of bioink for a particular
process is an essential step, as the selected bioinks should have desired physicochemical
properties that include mechanical, chemical, biological, and rheological characteristics.

In a bioink, cells are a mandatory component of the printing formulation in the form of single
cells, coated cells, or cell aggregates (of one or several cell types) or also in combination with
materials (for example, seeded onto microcarriers, embedded in microgels, formulated in a
physical hydrogel, or formulated with hydrogel precursors). In the case of biomaterial ink, in
principle, any biomaterial can be used for printing, and cell-seeding occurs post-fabrication.

The bioinks used in the bioprinting process should have the following properties:
1. The bioinks used should provide adequate mechanical strength and robustness while
maintaining the tissue-matching mechanics in the resulting tissue constructs.
2. The bioink molecules should have adjustable gelation and stabilization to achieve high
shape fidelity during bioprinting.
3. The bioinks should be biocompatible and undergo biodegradability according to
the natural microenvironment of the tissue.
 4. The bioinks should be suitable for chemical modifications to form specific tissues.

Figure: Distinction between a bioink (left side) and a biomaterial ink (right side).

Bioprinting Materials
Bioprinting materials, also known as bioinks, are specifically designed to be compatible with
living cells and provide a supportive environment for their growth and organisation. Here are
some examples of commonly used bioprinting materials:
• A single component of the ECM (e.g, gelatin, collagen, fibrinogen).
• An exogenous polymer (e.g., alginate, chitosan, agarose).
• Synthetic polymers, such as polycaprolactone (PCL) and poly (lactic-co-glycolic acid)
(PLGA).
• dECMs mimic the natural tissue microenvironment and support cell adhesion and
differentiation.

Hydrogels: Hydrogels are water-based polymer networks closely mimicking living tissues'
extracellular matrix (ECM). They offer excellent biocompatibility, mechanical support, and can
be formulated to have similar physical properties to native tissues. Examples of hydrogels used
as bioinks include:
• Gelatin-based hydrogels
• Alginate hydrogels
• Fibrin-based hydrogels
• Collagen-based hydrogel

Cell-laden Aggregates: In some cases, cells are first aggregated into biomolecules and biomaterials (or
micro-tissues) before being incorporated into the bioink. These aggregates provide a more physiological
environment for the cells and enhance their viability and functionality.

Figure. Process of cell-laden aggregates to organoids.

Decellularized Extracellular Matrix (dECM)

The extracellular matrix (ECM) is a complex network of molecules surrounding cells in tissues
and organs. It provides structural support, biochemical signalling, and regulatory function. The
ECM of tissues can be extracted and processed to remove cellular components, resulting in a
decellularised extracellular matrix (dECM). dECM bioinks contain natural signalling molecules
and proteins that promote cell attachment, growth, and differentiation. Examples of dECM
bioinks include decellularized porcine small intestine submucosa, decellularized porcine or
bovine dermis and decellularized amniotic membrane.

Figure. Process of dECM preparation.

Synthetic polymers: Biocompatibility, homogeneity in degradation, and printability are the
main important factors for biomaterials with the application in 3D bioprinting. In general terms,
biomaterials are natural and/or synthetic substances (in biological apparatus) being used for
repair or even replace any organ of the body. Relying on their chemical nature, they are
classified into four groups as metals, polymers, ceramics, and composites. Metals have high
mechanical strength, as well as composites or ceramics, whereas the corrosion resistance of
ceramics and composites is higher compared to other groups of materials. Notably, polymers are
biocompatible and biodegradable, while compared to other thermoplastic polymers are the most
applicable materials in 3D bioprinting. However, in 3D bioprinting, they are classified into two
main groups: synthetic polymers and natural polymers. Synthetic polymers have better
properties related to their structures and mechanical properties; there are fewer limitations in
their fabrication procedure. Natural polymers have low solubility and high viscosity as a result of
their high molecular weight. Synthetic polymers contributed as highly applicable materials in 3D
bioprinting due to the provided features such as high strength, dominant microstructure, and
controllable degradability. In what follows, a brief description of highly important synthetic
polymers is collected:

Polylactic Acid (PLA): PLA is hydrolytically degradable aliphatic polyester and has properties
including biocompatibility, degradability, and printing ability that make it a prominent polymeric
bioink. PLA is the main polymer which is used as a precursor in the FDM technique. Generated
filaments with PLA can be used in musculoskeletal tissue engineering for substituting ligaments
and non-biodegradable fibers. The degradation of PLA releases acidic by-products and spoils its
long-term biocompatibility by triggering tissue inflammation and cell demise. Furthermore, the
brittleness of PLA makes its general strength lower than that of bone and hence limits its usage.
The limitation can be overcome by merging it with low-cost ceramic materials, such as calcium
phosphate. It forms scaffolds of improved bone strength and reduces acid generation.

Poly-D,L-Lactic Acid: Poly-D,L-Lactic acid (PDLLA) is a polymer with a lactic acid origin and
amorphous structure. It is naturally hydrophobic and possesses convenient biocompatibility with
persistent mechanical characteristics that lead it to biomedical applications, particularly in SLA
techniques. It is one of the widely used polymers in forming biocompatible and porous scaffolds.
Thus, it is applied in resorbable devices of orthopedic rehabilitation and tissue engineering.
PDLLA, as a hydrophobic material, does not permit water diffusion in its matrix and extends the
decaying process. However, the existence of hydrophilic groups elevates the water uptake and
therefore prevents the decay. Meanwhile, such inclusion of hydrophilic groups can degrade the
polymer to monomer by lowering the pH and cause unfavourable allergic and inflammatory
reactions in the body.

Acrylonitrile Butadiene Styrene (ABS): Acrylonitrile butadiene styrene (ABS) is a triblock

copolymer with a petrochemical origin. ABS is linked to the chemical family of styrene
terpolymer with permissible strength and toughness. The low melting point (105 °C) of this
material increases its applications. The ABS is made of three different monomers that provide
several beneficial characteristics, including heat endurance, which is provided by acrylonitrile,
robust impact strength, which is derived from butadiene and styrene, that imparts rigidity. ABS
is used as a precursor in technologies such as fused deposition modelling (FDM) and selective
laser sintering (SLS) printing technologies. It is also used in cartilage engineering technologies.
Meanwhile, the application of this material is limited by its divested biodegradable nature,
identical cell integration and its processability that is like polylactic acid (PLA).

Polyethene Glycol (PEG): Polyethene glycol (PEG) is a hydrophilic polymer produced by

radical polymerisation reaction. It has a linear or branched structure that contains asymmetric or
dissymmetric hydroxyl ions as its tail groups. The enhanced biocompatibility elevated PEG as
mostly used material in drug delivery systems, tissue engineering scaffold formation, and surface
modifications to produce amphiphilic lock copolymers and ionomers. PEG is resistant to protein
adsorption and cell adhesion in nature and mainly forms a hydrogel. They are non-
biodegradable, and they have poor mechanical strength. Also, their non-biodegradability is
attached to the presence of a C–C polymer backbone. Nevertheless, the degradability of PEG is
often caused by hydrolytic and enzymatic degradation.

Polyether Ether Ketone (PEEK): Polyether ether ketone (PEEK) is a non-biodegradable

polymer with superior biocompatibility, low heat conductivity, radiolucent and comparable bio-
inertness. The semi-crystalline nature of the material provides permissible heat resistance and
chemical stability. It has strength and elasticity comparable to cortical bone, which diminishes
the chance of osteopenia after implementation by minimising the stress shielding. PEEK is
widely used in FDM and SLS technologies, including bioinks in prototyping craniofacial
implants and bone replacement. The peculiar radiolucent property provides an advantage in
orthopaedic applications by allowing radiographic evaluation. The submissive bioinert nature
suppresses osteointegrative properties and accordingly limits its applicability for tissue
engineering. It also has the potential to catalyze reactions, including dislodging, encapsulation,
and extrusion in the body, affecting the body tissues. In addition, its high melting point of ∼345
°C retards its application in the SLS technique.

Poly-glycolic acid (PGA): Poly-glycolic acid (PGA) is categorized as a main synthetic polymer
in 3D scaffold architecture because of its chemical versatility, ease of processing, alongside
biocompatibility and biological features. The biodegradation of PGA produces glycolic acid
monomer, which is simply removed from the body by certain catabolic pathways in the form of
carbon dioxide and water. Furthermore, the physical and mechanical properties of PGA can be
maintained by its copolymers. PGA is used in bone internal fixation devices and the preparation
of resorbable sutures. Compared to PDLLA, the degradation products of PGA are not toxic. The
seeding density and spreading of the cells can be boosted by surface functionalization of PGA
through hydrolysis of ester bonds. Although the hydrolysis technique provides useful features, it
can be restricted by its restructuring of surface morphology and mechanical strength. It is
susceptible to bulk erosion, resulting in the scaffold collapsing, thereby liberating acidic
degradation products that affect the body.

Poly Caprolactone (PCL): PCL offers great bioink features, including stiffness,
 biocompatibility, and degradability, and it is a relatively less expensive polymer. PCL is one of
the nontoxic polymers that tolerate significant stability. Generally, stability continues for 6
months with a biological half-life of 3 years. SLS-printed PCL scaffolds possess characteristics
such as a poriferous structure that leads to interconnectedness, a rough surface, and comparable
compactness to bone that result in bone regeneration and cell ingrowth capability. However, its
longer biological half-life develops a secondary obstacle in scaffolds made for applications other
than bone tissue engineering. Moreover, its higher hydrophobicity feature causes low bioactivity,
which means slow cell growth and tissue adhesion.

Polylactic-co-glycolic acid (PLGA): Polylactic-co-glycolic acid (PLGA) is a polymer with

reliable biodegradable nature and conspicuous cytocompatibility properties. It has mechanical
features equal to those of human calcareous bone and is osteoconductive. PLGA is also used in
bone regeneration animal models and many tissue-restoring systems. Nevertheless, the
hydrophobic feature limits its application. Moreover, its linear structures lead to poor mechanical
stiffness, high degradation rate, and, as a result, limit its usage as a scaffold material. The
broken PLGA debris in vivo tests are susceptible to an increased inflammatory reaction, and this
fracturing can be decreased by mixing it with PCL.

What are Bioprinters?

Three-dimensional (3D) bioprinting uses 3D printing–like techniques to combine cells, growth
factors, and other biomaterials to fabricate biomedical structures to imitate natural tissue
characteristics. 3D bioprinting uses a layer-by-layer method to deposit bioinks to create tissue-
like structures that are later used in various medical and tissue engineering experiments. This
article focuses on the types of 3D printing technologies and how they differ from each other.
Bioprinters or 3D bioprinters are automated devices for the additive fabrication of 3D functional
tissues and organs based on digital models created via various scans using biomaterials.
• Bioprinters are automated robotic devices that work based on different mechanisms.
• 3D printers that can only print cell-free scaffolds but cannot dispense living cells are
not considered bioprinters.
• The first commercial 3D bioprinter was prepared in Germany at Freiburg University
by Prof. Ralf Mulhaupt’s group.
• The evolution of 3D bioprinters is a continuous process that involved the
hybridization of new technological approaches to creating new advanced forms of
bioprinters.
• There are different types of bioprinters depending on the technique of bioprinting
employed by the machines: inkjet bioprinters, extrusion-based bioprinters, and laser-
based bioprinters.
• These bioprinters work on different mechanisms and are generally used for different
purposes depending on the type of biomaterials used.

Bioprinter Components
The size of the printers is dictated by the functional specifications, depending on the desired bio-
printed tissue or organ construct. The number of nozzles or openings also depends on the
 functional specification of the device. Other specific components, like laser sources and
temperature controls, are different in different types of bioprinters. Different types of bioprinters
have different components. Still, these bioprinters share some common characteristics with five
main structural-functional components: robotic positioning in the X-Y-Z axis, nozzle or
disperser or extrusion machine, operational or controlling system, and receiver substrate.
Head mount: The head of the printer is attached to a metal plate that runs along the horizontal
axis. The motor on the x-axis moves the metal plate side by side to deposit the biomaterial
horizontally.
Elevator: The elevator is a metal track running vertically at the back of the machine. It is driven
by the z-axis motor that moves the head of the printer in an up-and-down direction.
Platform: The platform is a shelf at the bottom of the machine that provides a space for the
organ to rest during fabrication. The platform can either be a scaffold or a Petri dish. A third
motor is also present in the printer that moves the platform along the y-axis.
Reservoirs: The reservoir is on the print head holding the biomaterial to be deposited during
printing.
Nozzle: The biomaterial in the reservoir in the print head is forced out through a small nozzle or
syringe just above the platform.

Figure. State of the art of 3D Bio printing Technology.

Types of 3D bioprinting technologies

1. Extrusion-based bioprinting: The extrusion-based 3D bioprinting utilizes either semi-solid
extrusion (SSE) or fused deposition modeling (FDM) based 3D printing. It has been widely used
in various biomedical sectors and enables the production of models that mimic soft tissues and
bone structures, which in turn provide an opportunity for possible implants.

2. Inkjet-based bioprinting: Inkjet bioprinting is a non-contact method based on the ejection of

drops of liquid onto a substrate by thermal, electrostatic, or piezoelectric forces. This technique is
comparatively more acceptable in terms of cost and compatibility with living materials and has the
advantage of high-speed construction of droplet bioinks.

3. Pressure-assisted bioprinting: Pressure-assisted bioprinting is based on the extrusion of

biomaterials out of the nozzle of the printer to fabricate a 3D biological structure that allows room
temperature processing and direct incorporation of homogenous cells onto the substrate. The
pressure is created by a coordinated motion of pneumatic pressure or plunger or via screw-based
pressure in the form of a continuous filament.

4. Laser-assisted bioprinting: Laser-assisted bioprinting method deposits biomaterials onto a

surface by using a pulsed laser beam as a source of energy. The principle of laser-assisted
bioprinting is the use of a laser to induce the transfer of biomaterials onto a solid surface. It causes
the liquid biomaterial to evaporate and reach the substrate in droplet form. The substrate consists
of either biopolymers or a cell culture medium and assists in cellular adhesion and sustains the
growth of the deposited biomaterial.

5. Stereolithography: Uses light or laser to solidify a liquid photopolymerizable bioink layer by

layer. Allows high precision and resolution, but is limited to photopolymerizable materials.

Figure. Types of 3D bioprinters.

5. Magnetic bioprinting: Magnetic 3D bioprinting involves assembling the layers of cells or

magnetic nanoparticles onto a substrate using a magnetic field. The magnetic field guides the
spatial arrangement of cells or nanoparticles into a specific pattern to create a biologically relevant
3D structure. Rely on magnetically labelled cells or particles that are guided to specific locations.
Non-contact and potentially higher cell viability.

Applications of magnetic 3D bioprinting

1. Regenerative medicine: By using cells isolated from patients, the resulting tissue constructs
can be used for implantation without the risk of rejection. This way, 3D magnetic bioprinting
has the potential to create customized implants for regenerative medicine.
2. Tissue engineering: Magnetic 3D bioprinting can create complex tissue constructs mimicking
the structure and function of native tissues, which can be used for in vitro drug testing and
disease modeling.
3. Drug screening: Precise control of cell positioning offers accurate and relevant conditions for
drug testing, since the cells are arranged to mimic the native tissue environment.

Advantages of 3D magnetic bioprinting over traditional bioprinting:

1. Precise and accurate: Magnetic field allows for precise control over cell positioning and
orientation during the printing process, enabling the creation of complex, functional tissue-like
structures.
2. Versatile: Magnetic 3D bioprinting can be used for a variety of cell types, including stem cells,
primary cells, and cell lines.
3. Customizable: It enables the design and printing of 3D structures with specific shapes and
sizes for the creation of customised tissue-like constructs matching the individual needs of
patients.
4. Reduced cell damage: The Magnetic 3D bioprinting technique is biocompatible and non-toxic,
minimizing cell damage during the printing process.
5. Scalable: The ability to create large-scale 3D structures allows us to produce tissue-like
constructs that can be used in clinical applications.

Overall, 3D magnetic bioprinting is a promising technology for tissue engineering, drug discovery,
and regenerative medicine.

How does a Bioprinter work?

• The bioprinting process begins with the CT or MRI scans of the desired organ. The image
thus obtained is loaded into a computer that builds a corresponding 3D blueprint of the
organ using a software program.
• The information from the 3D data is combined with histological information based on
 microscopic analysis to produce a layer-by-layer organ model.
• The information is then fed into the printer. Besides, other information about the material
to be used is also entered into the printer.
• The printer reads the blueprint and deposits the biomaterial onto the receiver layer by layer.
• It is achieved by moving the print head in all directions to generate the required depth and
thickness.
• Once a layer reaches the platform, it solidifies by cooling or chemical reaction. A new layer
is deposited to form a stable structure on the solidified layer.
• The organ thus formed is removed from the printer and placed in an incubator to allow
the structures to settle and stabilize.

The Basic Steps of the Bioprinting Process

Preparation of the bioink: The bioink used in bioprinting is a mixture of cells, growth factors,
and other biological materials formulated to promote cell growth and tissue formation.

Design of the tissue structure: The tissue structure to be printed uses computer-aided design
(CAD) software, which is then used to control the movement of the bioprinter's print head.

Printing: The bioprinter dispenses the bio-ink in a controlled manner, layer by layer, to build up
the final tissue structure. The bioink is deposited to promote cell survival and tissue
formation.

Incubation: After printing, the tissue is incubated in a controlled environment, such as a cell
culture incubator, to promote cell growth and tissue formation.

Assessment: The printed tissue is assessed for its functional properties, such as cell viability,
tissue structure, and tissue function. The field of bioprinting is constantly evolving, and new
techniques and materials are being developed to improve the accuracy and reliability of bio-
printed tissues and organs.
Figure. Working steps of a bioprinting process.

Figure. Applications of 3D printed tissues.

3D Bioprinting Applications
1. Tissue engineering
• Tissue engineering is one of the most prominent applications of 3D bioprinting. It enables
the fabrication of complex tissues and organs that replace failed or lost tissues.
• Production of functional tissues and organs at clinically relevant dimensions is challenging
as integrating the vascular network of arteries and veins and incorporating various cell
types to reinvent complex organ biology is difficult to achieve.
• Nevertheless, various tissues have been successfully printed while maintaining mechanical
integrity and functioning.

Examples of tissues that have been printed for various purposes are;
a. Skin
• Several tissue engineering approaches achieve skin tissue fabrication.
• Tissue engineering can be done to produce substitutes like an autologous split-
thickness skin graft, allografts, a-cellular dermal substitutes, and cellularized graft-like
commercial products.
• Bioprinting skin tissue can be done using an eight-channel valve-based bioprinter
where a 13-layer tissue is constructed using collagen hydrogel.
• Keratinocytes are then printed on top of alternating layers of human foreskin
fibroblasts and acellular collagen layers to fabricate constructs with densely packed cells
in epidermal layers.
• The tissue constructs prepared are engrafted with the host after about ten days in the
stratified epidermis.

b. Bone and cartilage

• Bone and cartilage fabrication is the most mature use of bioprinting, as the
composition of such hard tissues is uncomplicated and is mainly composed of inorganic
elements.
• Even though techniques like gas foaming, salt leaching, and freeze-drying have been
employed to produce such hard tissues, 3D bioprinting constructs the most accurate
structures.
• A thermal inkjet bioprinter fabricates polymethacrylate scaffolds from bone marrow-
derived human mesenchymal stem cells.
• The cells are printed along with nanoparticles of bioactive glass to control the spatial
placement of cells.
• In cartilage tissue engineering, a printable bioink combines nano-fibrillated cellulose
and alginate with human chondrocytes as living soft tissue.

c. Blood vessels
• Bioprinting of vascular networks is essential as the fabrication of tissues and
organs depends on vascularisation to provide oxygen and media to the printed
constructs.
• The bioprinting technology that produces bioprinted vascular networks includes
extrusion- and laser-assisted bioprinting techniques.
 • During bioprinting, hydrogen gels, including sodium alginates and chitosan, are
bioprinted directly in tubular form with encapsulated cells.
• The tubular structures thus formed have improved metabolic transportation and cellular
viability.

d. Liver tissue
• Bioprinting of liver tissue is comparatively less prevalent, as the liver cells have a strong
regeneration ability.
• However, healthy donors are limited, and the regeneration period for such a liver is long.
• The bioink used for this purpose includes cells like primary and stem-cell-derived
hepatocytes.
• 3D printing technology can provide the exact size and shape of the liver, which is suitable
for the patient.
• Bioprinting produces canaliculi linked together by the collagen matrix to form larger
structures.

2. Drug development/screening
• Drug discovery requires time-consuming and costly processes that demand
substantial financial investment and workforce.
• Thus, developing a technique to improve the ability to predict the efficacy and
toxicity of newly developed drugs earlier in the drug discovery process helps reduce the
time and money required.
• Bioprinting can fabricate 3D tissue models that resemble that of native tissue and are
capable of high-throughput assays.
• Most commonly, liver and tumor tissues are the primary focus of creating tissue models for
pharmaceuticals.
• Besides, depending on the target cells of developed drugs, the tissue models of such cells
can be prepared and tested.
• Initially, tissue constructs of epithelial cells are prepared as these cells form the lining
through which the drug diffuses into the bloodstream.
• Based on the studies on such constructs, the path of drugs and their action on the target cells
can be assumed.
• Similarly, bioprinting can be used as an alternate way to develop prescription drugs.
• The drugs can even be customized for each patient by preparing appropriate doses of drug
print by using a set of biochemical inks.
• 3D-printed composite pills containing multiple drugs with unique release rates can be
used instead of taking various medications throughout the day.

3. Toxicology Screening
• Toxicology screening or testing identifies potential adverse effects of chemicals on
individuals or the environment.
• Chemicals might include pharmaceutical ingredients, cosmetic ingredients, household,
and industrial chemicals.
• Studies evaluating the toxicity of some chemicals might require a more significant
 number of human subjects with diverse metabolisms, which might seem unethical.
• Some studies can be performed on animals, but animals might not predict human
responses accurately or reliably.
• Instead, 3D bioprinting can provide a highly automated and advanced technology that
can produce constructs that mimic the structure and function of human tissues.
• The use of such constructs facilitates real-time monitoring and high throughput
screening of various chemicals.
• Testing of cosmetic ingredients on human-relevant skin tissue models has been performed
for a long time.
• These tests study skin absorption, irritation, corrosion, and sensitization on models
mimicking human tissue structures.

4. Tissue model for cancer research

• 2D tumor models have been used in cancer research for a long time, but those do
not represent the physiologically relevant environment, as the 2D models lack cell-cell
interactions.
• However, 3D bioprinting allows the recapitulation of the cancer microenvironment to
study cancer pathogenesis and metastasis accurately.
• Multiple cell types can be simultaneously bioprinted to form multicellular structures
reproducibly with a spatially mediated microenvironment and controlled cell density and
cell-cell distance.
• Bioprinting of HeLa cells can be done in a gelatin-alginate composite hydrogel to study
cell aggregation.
• These tissues can be used to study the progression of cancer and the changes in tissue
structure and function.
• Besides, tissue models can also be used to study the efficiency of treatment methods
against various carcinogens.

Limitations and Future Challenges of 3D Bioprinting

• The primary barriers in bioprinting are suitable bioinks with high biocompatibility and
mechanical strength.
• Bioprinter technology currently has comparatively lower resolution and speed, which
challenges future development. Similarly, bioprinters should also be compatible with a
broad spectrum of biomaterials.
• The speed of the bioprinting process should be increased to mass-produce biomaterials at
a commercially acceptable level, as the current rate is slow.
• Vasculature of tissue constructs is an essential challenge in 3D bioprinting as the
tissues require continuous oxygen and nutrients.
• There are some ethical issues with 3D bioprinting, as the cost of the method might make it
inaccessible to low-income people.
• Because bioprinting is a novel technology, it should be studied sufficiently to ensure it
will be safe for humans.
• Personalized 3D printing technology might lead to regulatory problems in ensuring
printed products.
3D Printing of the Ear
Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill
Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that
looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers
the promise of grafts with well-defined anatomy and the correct biomechanical properties for
those who are born with a congenital malformation or who lose an ear later in life. Many
surgeons build a replacement ear using cartilage removed from a child's ribs, an operation that
can be painful and scary. And though the resulting graft can be crafted to resemble the recipient's
other ear, it generally does not have the same flexibility. This process involves using a 3D
printer to create an ear-shaped structure using a particular material, such as a biocompatible
polymer or a hydrogel, as the "ink." The printed ear structure is then seeded with human cartilage
cells, which grow and develop into functional ear tissue over time. One way to produce a more
natural replacement ear is to enlist the aid of chondrocytes, the cells that build cartilage. In
earlier studies, Dr. Spector and his colleagues used animal-derived chondrocytes to seed a
scaffold made of collagen, a key component of cartilage. Though these grafts developed
successfully at first, over time, the well-defined topography of the ear - its familiar ridges,
curves, and whorls - was lost. "Because the cells tug on the woven matrix of proteins as they
labor, the ear contracted and shrank by half," said Dr. Spector. To address this problem in this
study, Dr. Spector and his team used sterilized animal-derived cartilage treated to remove
anything that could trigger immune rejection. This was loaded into intricate, ear-shaped plastic
scaffolds that were created on a 3D printer based on data from a person's ear. The small pieces of
cartilage act as internal reinforcements to induce new tissue formation within the scaffold. Much
like rebar, it strengthens the graft and prevents [Link] the next three to six months, the
structure developed into cartilage containing tissue that closely replicated the ear's anatomical
features, including the helical rim, the "anti-helix" rim-inside-the-rim and the central, conchal
bowl. "That's something that we had not achieved before," said Dr. Spector. To test the feel of
the ear, biomechanical studies were performed in conjunction with Dr. Spector's long time
engineering collaborator Dr. Larry Bonassar, the Daljit S. and Elaine Sarkaria Professor in
Biomedical Engineering at the Meinig School of Biomedical Engineering on Cornell's Ithaca
campus. This confirmed that the replicas had flexibility and elasticity like human ear cartilage.
However, the engineered material was not as strong as natural cartilage and could tear. To
remedy this issue, Dr. Spector plans to add chondrocytes to the mix, ideally ones derived from a
small piece of cartilage removed from the recipient's other ear. Those cells would lay down the
elastic proteins that make ear cartilage so robust, producing a graft that would be
biomechanically much more similar to the native ear, reducing the risk of complications
associated with traditional surgical methods.

Figure: Low-cost soft tissue prostheses (He et al. Sci Rep 4, 6973 (2014).
[Link]

The main advantage of 3D printing an ear is that it allows creating an ear custom-fitted to an
individual patient, based on their ear shape and size. This can be especially useful for children
with congenital ear deformities or individuals who have suffered ear injuries or losses.
Additionally, 3D printing can also be used to create ears that are anatomically and functionally
similar to a patient's normal ear, reducing the risk of complications associated with traditional
surgical methods.

Materials Used for 3D Printing of the Human Ear

The material used for 3D printing of human ears can vary depending on the specific techniques
and desired outcome. Some of the most commonly used materials for the 3D printing of ears
include:

Hydrogels such as alginate, gelatin, and collagen are used in the 3D printing of ears. It provides a
supportive structure for the cells to grow and develop into functional tissue due to its ability to
mimic the mechanical properties of human ear tissue.

Biocompatible polymers such as Polylactide (PLA) are used in 3D printing of ear structures
due to their biocompatibility and ability to support cell growth.

Scaffolds provide a supportive framework for the cells to grow and develop into tissues and,
hence, are used for the fabrication of an ear.

Cell-embedded materials contain living cells, which can be used to seed the 3D-printed
structure. The cells then grow and develop into functional ear tissue over time.

Ceramics, such as hydroxyapatite, can be used in the 3D printing of ear structures.

Importance of 3D Printing of the Human Ear

3D printing allows for creating customised ear prostheses that match each patient's unique
anatomy.
Traditional methods of ear prosthetics fabrication can be time-consuming and expensive. 3D
printing can reduce the production time and cost of ear prosthetics.

3D printing can use biocompatible materials to produce ear prostheses, reducing the risk of
adverse reactions and improving patient outcomes.

3D printing of human ears can educate medical students and healthcare professionals on the
anatomy and treatment of ear defects and injuries.

3D-Printing of Skin
3D printing of skin refers to creating three-dimensional human skin tissue using a 3D printer. The
goal of 3D printing skin is to create functional, living tissue that can be used for various purposes,
such as cosmetic testing, wound healing, and drug development. The process involves
bioprinting technology, where a bioink made from living cells and growth factors is printed in a
specific pattern to create the desired tissue structure. In a world-first breakthrough for burns
treatment, researchers at Concord Hospital have successfully developed a technique to 3D print
skin from a patient's own cells and apply it directly to their wound. The process uses advanced
techniques developed by Inventia Life Science, creators of the Ligo Surgical Robot, which prints
biomaterials directly onto the wound with precision, helping a surgeon to rebuild lost tissue after
trauma.3D bioprinting allows for sheets of artificial skin to be printed for grafts. There is a major
drawback, however: the sheets it produces are flat and with open edges — ill-adapted to the
geometry of the body.

Figure: Image of a 3D-printed skin.

The Process of Printing 3D Skin
A bioink is made by mixing human skin cells, such as fibroblasts and
keratinocytes, with a Hydrogel matrix that provides a supportive environment for cell growth.
The tissue structure to be printed is designed using computer-aided design (CAD)
software, which is then used to control the dispensing of the bioink. The bioink is printed layer
by layer using a 3D printer to create the desired tissue structure. After printing, the tissue is
incubated in a controlled environment, such as a cell culture incubator, to promote cell growth and
tissue formation. The printed tissue is assessed for its functional properties, such as cell
viability, tissue structure, and tissue function.

Materials used for 3D printing of Skin are Hydrogels like alginate and collagen are
hydrophilic materials that can create 3D structures for cell growth. These materials have been
used in the 3D printing of skin due to their ability to mimic human skin's mechanical properties
and water-retaining capacity. Biocompatible polymers, such as polyethylene glycol and
polycaprolactone, Cell-laden hydrogels contain living cells and can be used to create 3D-printed
skin structures. Scaffolds provide a supportive framework for cells to grow and develop and can
be used to create a specific shape or structure for skin tissue to grow around. The choice of
material will depend on several factors, including the specific 3D printing technique used for the
desired outcome and the intended use of the 3D-printed skin.

Figure: The complete process of 3D skin printing and its application.

Importance of 3D Printing of Human Skin
3D printing of skin can produce customized skin grafts that promote wound healing and reduce the
risk of infection. This is particularly important for patients with bums, chronic wounds, or other
skin injuries. It can promote more natural healing and reduce scarring, improving the cosmetic
appearance of the skin after injury. 3D printing of skin can provide an alternative to animal
testing in the cosmetic and pharmaceutical industries, reducing ethical “concerns and improving
the accuracy and relevance of testing. 3D printing of skin can be used in research and
development to study the properties and behavior of different skin types, test the effectiveness of
new treatments, and develop new skin care products.
Muscular Systems as Scaffolds
The use of muscular systems as scaffolds in regenerative medicine is an area of active research
and development. Muscles have the potential to be used as scaffolds for the regeneration of
tissues due to their inherent mechanical properties and ability to support cell growth and tissue
formation. One example of using muscular systems as scaffolds is in the treatment of damaged
or diseased heart tissue. Researchers have developed methods for using muscle cells to create a
functional, three-dimensional scaffold that can support the growth of new heart tissue. In this
approach, muscle cells are harvested from the patient and then seeded onto a scaffold, such as a
hydrogel or artificial matrix. The scaffold provides a framework for the cells to grow and
differentiate into new heart tissue, which can help to repair the damaged or diseased tissue.
Another example is in the treatment of skeletal muscle injuries, such as those caused by trauma
or disease. In this case, muscle cells can be harvested and seeded onto a scaffold, which can then
be implanted into the damaged muscle to promote the growth of new, functional tissue. While
the use of muscular systems as scaffolds is still in the experimental stage, it holds great promise
for the treatment of a variety of conditions and represents an area of active research and
development in the field of regenerative medicine.

Architecture
The musculoskeletal system (locomotor system) is a human body system that provides our body
with movement, stability, shape, and support. It is subdivided into two broad systems: Muscular
system, which includes all types of muscles in the body. Skeletal muscles, in particular, are the
ones that act on the body joints to produce movements. Besides muscles, the muscular system
contains the tendons, which attach the muscles to the bones. Besides its main function to provide
the body with stability and mobility, the musculoskeletal system has many other functions; the
skeletal part plays an important role in other homeostatic functions such as storage of minerals
(e.g., calcium) and hematopoiesis, while the muscular system stores most of the body's
carbohydrates in the form of glycogen.

Skeletal system, whose main component is the bone. Bones articulate with each other and form
the joints, providing our bodies with a hard-core, yet mobile, skeleton. The integrity and function
of the bones and joints are supported by the accessory structures of the skeletal system; articular
cartilage, ligaments, and bursae. Inside each skeletal muscle, muscle fibers are organised into
bundles, called fascicles, surrounded by a middle layer of connective tissue called the
perimysium. This fascicular organization is common in muscles of the limbs; it allows the
nervous system to trigger a specific movement of a muscle by activating a subset of muscle
fibers within the fascicle of the muscle. Inside each fascicle, each muscle fiber is encased in a
thin connective tissue layer of collagen and reticular fibers called endomysium. The
endomysium surrounds the extracellular matrix of the cells and plays a role in transferring force
produced by the muscle fibers to the tendons. Inside the muscle fibers, there are tiny structures
called myofibrils. Myofibrils are made up of smaller units called sarcomeres, which are
responsible for muscle contraction.
 Figure: Representing the sarcomere.

Sarcomeres contain thin (Actin) and thick filaments (Myosin) that work together to make the
muscle fibers contract. Each muscle fiber is surrounded by a protective layer called
endomysium. Multiple muscle fibers are grouped into bundles called fascicles. Fascicles are
surrounded by another layer of connective tissue called perimysium. All the fascicles together
make up the entire muscle, which is surrounded by a layer called epimysium. The muscle also
has a special membrane called the sarcolemma, which protects the muscle fiber. Inside the
muscle fiber, there are small tunnels called T-tubules that help transmit signals for muscle
contraction. Muscles work through the coordination of motor units, which consist of a motor
neuron and the muscle fibers it controls. This architecture allows muscles to
generate force, move our bodies, and perform various activities.

Mechanisms
The mechanism of how the muscular system can be used as a scaffold in regenerative medicine
involves the use of muscle cells and a scaffold to support the growth and regeneration of new
tissue. The method of growing muscle tissue using a hydrogel or an artificial scaffold is
explained below:

Harvesting of muscle cells: Muscle cells are typically obtained from the patient and then
isolated and expanded in culture.
Seeding onto a scaffold: The muscle cells are then seeded onto a scaffold, such as a hydrogel or
artificial matrix. The scaffold provides a framework for the cells to grow and differentiate into
new tissue.
Cell differentiation and tissue formation: Once the cells are seeded onto the scaffold, they
undergo differentiation, in which they change into specific cell types, such as muscle cells or
heart cells. The cells also begin to organize and form new tissue, such as heart tissue or skeletal
muscle tissue.
Implantation into the patient: The scaffold and cells are then implanted into the patient to
promote the growth of new, functional tissue.
Figure: Muscle tissue growth using a hydrogel or an artificial scaffold.

Figure: Formation of a polymer-based scaffold and cell culture.

Muscle Cells as Scaffold
Muscle cells can be used as a scaffold for tissue generation by removing the living cells from the
muscle tissue, leaving behind the structure known as the extracellular matrix (ECM). This
decellularized muscle scaffold provides a framework that can guide and support the growth of
new tissues.

Figure: Muscle scaffold for tissue growth.

The Process
Harvesting muscle tissue: A small sample of muscle tissue is taken, typically from a donor or
an animal model.
Cell removal: The living cells within the muscle tissue are removed using a process called
decellularization. This involves treating the tissue with specific chemical solutions or enzymes
that break down and wash away the cellular components, while preserving the ECM.
ECM scaffold: The remaining ECM, which forms the structure of the muscle, is now a scaffold.
It consists of proteins, such as collagen and elastin, and other molecules that provide support and
signals for tissue growth.
Seeding cells: The decellularized muscle scaffold is then seeded with desired cells. These can be
stem cells or specialized cells relevant to the type of tissue being regenerated. The cells are
introduced onto the scaffold, allowing them to attach and populate the structure.
Tissue growth: Over time, the seeded cells proliferate and differentiate, meaning they multiply
and transform into specific cell types required for the desired tissue. The ECM scaffold guides
the cells' growth, providing physical support and biochemical cues to influence their behavior.
Tissue integration: As the cells continue to grow, they populate the scaffold and form new
tissue. The new tissue integrates with the surrounding native tissue, gradually replacing the
decellularized scaffold with functional, regenerated tissue.
By utilizing the decellularized muscle scaffold, the process of tissue generation takes advantage
of the existing three-dimensional architecture and mechanical properties of the muscle. This
approach has the potential to address challenges in tissue engineering, such as creating a suitable
environment for cell growth, promoting vascularization, and facilitating functional integration of
regenerated tissues.

Bioengineering Solutions for Muscular Dystrophy Muscular dystrophy

Muscular dystrophy is a group of genetic disorders that result in progressive weakness and
degeneration of the skeletal muscles, which are responsible for movement. The disorders are
caused by mutations in genes that encode proteins needed for muscle function. The most
common type of muscular dystrophy is Duchenne muscular dystrophy, which typically affects
young boys and leads to severe disability by early adulthood. Other forms of the disease include
Becker muscular dystrophy, limb-girdle muscular dystrophy, and facioscapulohumeral
dystrophy, among others.

Figure. Common symptoms of muscular dystrophy.

Duchenne muscular dystrophy (DMD) usually appears early in childhood between the ages of 2
and 3. DMD primarily affects boys, but can affect girls in rare cases. The primary symptom of
DMD is muscle weakness that begins in the muscles close to the body and later affects muscles
in the outer limbs.

Becker muscular dystrophy typically becomes apparent between the ages of 5 and 15. It is
similar to Duchenne MD, except that it progresses more slowly and symptoms begin to appear
later. Boys are primarily affected by Becker's MD. Becker's MD causes muscle loss that begins
in the hips and pelvic area, thighs, and shoulders.

The age of onset of limb-girdle muscular dystrophy is highly varied, ranging from early
childhood to later adulthood. The disease is characterized by muscle weakness and atrophy of
the muscles of the hip and shoulder areas (the limb girdles).
Facioscapulohumeral dystrophy (FSHD) typically appears before the age of 20, but can appear
later in adulthood or even in childhood in both males and females.

FSHD affects the muscles of the face, around the shoulder blades, and in the upper arms.

There is currently no cure for muscular dystrophy, but various treatments can help manage
symptoms and slow the progression of the disease. These may include physical therapy, assistive
devices, orthopedic surgery, and medication to manage muscle spasms and pain. In some cases,
genetic therapy and stem cell transplantation are also being explored as potential treatment
options.

It's important for individuals with muscular dystrophy to work closely with a healthcare team
that includes specialists in neurology, rehabilitation medicine, and orthopedics, to develop a
comprehensive care plan that meets their specific needs.

Bioengineering solutions for muscular dystrophy

Bioengineering solutions for muscular dystrophy aim to improve the lives of individuals affected
by the disease by addressing the underlying genetic mutations and muscle weakness. Some of
the approaches being explored include:
Gene therapy: This involves delivering a functional copy of the missing or mutated gene to the
affected muscle cells. The goal is to restore the production of the missing protein and improve
muscle function.
Stem cell therapy: This involves using stem cells to replace the damaged muscle cells and
promote repair and regeneration of the muscle tissue. Stem cells can be taken from the patient's
own body (autologous stem cells) or from a donor (allogenic stem cells).
Exoskeleton technology: This involves using wearable devices, such as robotic exoskeletons, to
support and enhance the movement of individuals with muscular dystrophy. The devices use
motors and sensors to mimic the movements of the wearer and help improve mobility.
Tissue engineering: This involves using a combination of materials, such as scaffolds and
growth factors, to promote the growth and repair of muscle tissue. The goal is to create
functional muscle tissue that can replace the damaged tissue in individuals with muscular
dystrophy.
These approaches are still in the early stages of development but hold promise for the future
treatment of muscular dystrophy. Clinical trials and further research are needed to determine the
safety and efficacy of these therapies.

The traditional method of fabricating 3D muscle constructs, first developed more than 25 years
ago, involves casting myogenic cells within a cylindrically shaped collagen-I gel that is anchored
at the ends to porous felts. In this system, cell-mediated gel compaction and remodelling result
in the generation of uniaxial passive stress within the gel, which, in turn, promotes the fusion of
myoblasts into myotubes and myotube alignment. Alternatively, myoblasts, or mixtures of
myogenic precursors and fibroblasts, can be cultured on laminin- or hydrogel-coated dishes until
spontaneous contractions of formed myotubes detach the entire cell layer, allowing it to self-
assemble into a cylindrical tissue construct attached at the ends to premade suture anchors.
Although cell alignment within 3D constructs is not required for the formation of contractile
myotubes, it increases fusion efficiency while passive stress promotes both cell survival and
myogenesis. In addition to collagen I, different natural hydrogels and their chemically modified
derivatives can support the 3D growth and fusion of myogenic cells; the most functional results
have been achieved using fibrin-based gels. Carefully optimizing the composition of the fibrin
gel to enhance cell-matrix interactions as well as optimizing the starting cell population to
improve myogenic fusion and SC maintenance and providing dynamic culture conditions to
improve cell survival and maturation have enabled rodent skeletal muscle tissues to be
engineered with contractile properties comparable to those of native muscle (e.g., twitch and
tetanus-force amplitudes).
Rapid-prototyping techniques for hydrogel molding can be further used to vary local myofiber
alignment and to design complex muscle structures, and advanced biomaterials can deliver
angiogenic, myogenic, and pro-survival factors to cells in a spatiotemporally controlled fashion.
In addition to using biomaterial scaffolds, scaffold-free muscle tissue constructs have
beengenerated using magnetic fields that allow the controlled assembly of magnetically labeled
cells, as well as thermo-responsive polymers that allow controlled cell detachment from culture
surfaces.
Although hydrogels have been the dominant muscle-engineering scaffold in vitro, in vivo studies
of muscle repair have mainly utilized acellular natural scaffolds, porous matrices made of
degradable polymeric materials, or scaffold-free myoblast sheets.
 Bio-imaging for Disease Diagnosis
Bioimaging is a term that refers to a procedure in which there is no involvement in tools that can
invade the skin or physically enter the body, and it allows scientists to view biological functions
in real time. Bioimaging refers to methods and instruments used to acquire, process and visualize
structural or functional images of living objects or systems at desired spatial and temporal scales.
Bioimaging can also refer to techniques used to visualise fixed biological samples. Image
processing, data mining and big data analytics are important parts of bioimaging. Overall,
bioimaging aims not to interfere with life processes. It is generally non-invasive and often
provides information in real time. Visualization ranges from subcellular structures and cells to
entire multicellular organisms, tissues and organs. Bioimaging uses electromagnetic and
ultrasound waves as sources for imaging. Common imaging modalities include, but are not
limited to, x-ray, computed tomography (CT), positron emission tomography (PET), magnetic
resonance imaging (MRI), ultrasound, photoacoustics, optical coherence tomography,
fluorescence and optical microscopy. Furthermore, contrast agents, therapeutic agents, molecular
probes and nanosensors, which are used to understand biological processes at the molecular and
cellular level and to develop novel diagnostic tools and innovative therapies, are indispensable in
bioimaging.

Bioimaging can be used to create images of the whole body, anatomical areas, organs, tissues
and biological markers down to the molecular level. It can be applied directly for clinical
purposes, seeking to detect, diagnose, and characterize diseases, or to facilitate disease treatment
and monitoring. In basic and medical sciences, bioimaging can be used to study normal anatomy
and physiology and to gain information for research purposes. Cutting-edge bioimaging research
is integrative and often requires multidisciplinary teams with expertise in biology, physics,
chemistry, electrical engineering, mechanical engineering, biomedical engineering and other
fields. Multi-modal (e.g., combined ultrasound and light imaging) and multi-scale (e.g.,
molecular to cellular to organ) imaging is often needed for advanced applications of bioimaging.

Table: Major bioimaging techniques.

Technique Description Application
Uses visible light to magnify
specimens; includes brightfield, Basic cell imaging, labelled
Light Microscopy
phase contrast, and fluorescence protein tracking
microscopy
Uses lasers and pinholes to
Tissue imaging, neural
Confocal Microscopy create high-resolution, 3D
mapping
images
Electron Microscopy Uses electron beams for ultra- Organelles, viruses,
(SEM/TEM) high resolution macromolecular complexes
MRI (Magnetic Uses magnetic fields and radio Brain imaging,
Resonance Imaging) waves musculoskeletal diagnostics
PET (Positron Emission Detects radioactive tracers to Cancer, heart disease, and
Tomography) show metabolic activity brain function
 Ultrasound Imaging Uses sound waves Fetal imaging, organ scanning
Bioluminescence and Uses light from chemical Gene expression, tumor
Fluorescence Imaging reactions or fluorophores tracking in animal models
Combines optical and ultrasound Blood oxygenation, tumor
Photoacoustic Imaging
imaging detection

Technological Importance
The technological importance of bio-imaging for disease diagnosis lies in its ability to provide
detailed images of the body's internal structures and functions, which can help healthcare
professionals make accurate diagnoses and provide effective treatments. The key technological
advantages of bio-imaging include:
• Improved accuracy: Bio-imaging technologies can provide high-resolution images of the
body’s internal structures, which can help healthcare professionals identify subtle changes
and make accurate diagnoses.
• Early detection: Bio-imaging can detect diseases in their early stages when they are often
more treatable. This can lead to earlier treatment and better outcomes for patients.
• Multi-modality: Bio-imaging technologies can be combined to provide a multi-modal
view of the body's internal structures and functions, providing a more comprehensive
understanding of a disease or condition.
• Cost-effectiveness: Many bio-imaging technologies are relatively low-cost, which makes
them accessible to a broader range of patients.
• Minimally invasive: Many bio-imaging techniques are non-invasive, which means that
they do not require incisions or the insertion of instruments into the body. This makes
them less painful and less risky than many traditional diagnostic procedures.
• Improved patient outcomes: By providing healthcare professionals with detailed
images of the body's internal structures and functions, bio-imaging can help to improve
patient outcomes by enabling earlier and more accurate diagnoses, and more effective
treatments.
• Advancements in research: Bio-imaging technologies are also crucial in advancing
medical research, by providing detailed images of the body's internal structures and
functions, which can help researchers to understand the underlying mechanisms of
diseases better and develop new treatments.

Table: Comparison of the Most Common Clinical Imaging Techniques

X-ray CT MRI PET/SPECT Ultrasound Optical*
Source X-ray Magnetic field and γ-rays Sound Light
radiofrequency
Spatial 50–200 μm 25–100 μm 2–10 mm 50–500 μm 1–5 mm
resolution
Penetration No limit*** No limit*** No limit*** Several cm 1–10 cm (depending
depth on the technology
used)
Probes Heavy Magnetizable Radionuclide: 1 Microbubble, Fluorescent dye,
 8
element, materials: Fe3O4, F, 11C, 13N, 15 emulsion, quantum dots, near-
e.g., I, Ba, Gd chelates O, 64Cu, 124I 11I micelle infrared dyes
Au… n, 99mTc
Probe dose 10−3 10−3–10−5 10−10–10−12 Not Biolum: 10−15–
(mol/L) characterized 10−17 Fluo: 10−9–10−12
Information A and P A, P and F A, P and F A and P P and M
**
Advantages High High spatial High Easy, fast, no Multichannel imaging,
resolution, resolution, no sensitivity to ionizing no radiation, sensitive
no depth radiation, no depth probes radiation, cost- to probe dose
limit limit effective
Drawbacks Radiation, Poor sensitivity to Need for Depth limit Need for probes, not
poor soft probes, expensive probes, (cm), poor yet available in
tissue radiation, contrast, not clinics, low depth
delineation, expensive, low suitable for air- penetration, low
low resolution containing resolution
sensitivity organs
to probes
1. *Optical imaging includes bioluminescence (biolum) and fluorescence (fluo) modalities
2. **In vivo information: A: anatomical, P: physiological, F: functional and M: molecular
3. ***At the scales involved in clinical and preclinical studies
Artificial Intelligence for Disease Diagnosis
Artificial intelligence in medical diagnosis is revolutionizing the field of healthcare, offering new
levels of accuracy and efficiency. AI technologies, particularly in medical diagnostics, are
transforming into how diseases are detected, analyzed, and treated. By leveraging machine
learning and deep learning algorithms, AI can process vast amounts of data swiftly and accurately,
providing healthcare providers with invaluable insights. These advancements are not only
enhancing the precision of diagnoses but also enabling early detection and personalized treatment
plans. This article explores the various ways AI is reshaping medical diagnostics, with a focus on
its applications, benefits, and the challenges that come with integrating these cutting-edge
technologies into clinical practice.

The evolution of AI in healthcare has been transformative, especially in the field of medical
diagnostics. Initially, AI was primarily used for administrative tasks, but its role has expanded
significantly. Now, AI and machine learning algorithms analyze vast amounts of data quickly
and accurately, assisting healthcare providers in making more informed decisions. These
technologies can process medical images, recognize patterns, and even predict disease outcomes,
revolutionizing the practice of medicine.

Role of AI in Diagnosis:
• Enhanced Accuracy: AI algorithms improve diagnostic accuracy by analyzing complex
medical data, reducing human error.
• Early Detection: Machine learning models can identify early signs of diseases such as
cancer or heart disease, allowing for timely intervention.
• Personalized Medicine: AI tailors treatments based on individual patient data, leading to
more effective and personalized care plans.
• Efficiency: Automated systems speed up the diagnostic process, freeing up healthcare
providers to focus on patient care.

Benefits of AI in Healthcare:
• Data Analysis: AI processes large datasets from electronic health records (EHRs),
providing insights that are difficult to achieve manually.
• Imaging: Advanced AI tools enhance the interpretation of medical images, aiding
radiologists in identifying abnormalities.
• Predictive Analytics: Predictive models forecast disease progression, helping in preventive
care and better resource allocation.
• Clinical Decision Support: AI systems provide evidence-based recommendations,
supporting clinicians in making more informed decisions.

Challenges:
• Integration: Integrating AI systems with existing healthcare infrastructure requires
significant investment and training.
• Data Privacy: Ensuring the security of sensitive patient data is paramount.
• Regulation: Developing appropriate regulatory frameworks to oversee AI applications in
 medicine is essential.

Healthcare providers must embrace these advancements, addressing challenges such as

integration, data privacy, and regulation, to fully realize the potential of AI in transforming
health care.

Artificial Intelligence is Enhancing Diagnostic Accuracy

Artificial intelligence (AI) is significantly enhancing diagnostic accuracy in the medical field, often
outperforming traditional methods. For instance, in radiology, AI-powered algorithms can analyze
medical images with remarkable precision. Studies have shown that AI systems detect breast
cancer in mammograms more accurately than human radiologists. These AI tools analyze
thousands of images to recognize patterns and subtle changes that might be overlooked by the
human eye.

AI often outperforms the accuracy of traditional methods in burn and wound management. AI-
powered tools use advanced machine learning algorithms to analyze images of wounds, providing
rapid and precise assessments. These tools can identify infection, determine the depth of burns, and
monitor healing progress with greater accuracy than conventional techniques.

Moreover, AI algorithms have been developed to predict wound healing outcomes. These models
use patient data, including demographics, wound characteristics, and comorbidities, to forecast
healing trajectories. Such predictions help clinicians tailor treatment plans, optimize resource
allocation, and improve patient outcomes.

AI also excels in detecting diabetic foot ulcers. Machine learning models trained on large datasets
of foot images can accurately classify ulcer severity and recommend appropriate debridement
techniques. This level of precision reduces the risk of complications, such as infections and
amputations, thereby enhancing patient care.

In burn management, AI enhances diagnostic accuracy by analyzing burn images to determine the
need for surgical intervention. Traditional methods rely on subjective visual assessments, which
can vary between clinicians. AI tools, however, provide consistent and objective evaluations,
improving the accuracy of burn depth assessment and surgical planning.

Furthermore, AI facilitates early detection of infections in chronic wounds. Machine learning

algorithms analyze wound exudate and other clinical data to identify signs of infection before they
become clinically apparent. Early detection allows for prompt treatment, reducing the risk of
severe complications and promoting faster recovery.

By leveraging machine learning and advanced data analysis, AI tools provide healthcare providers
with precise, timely, and actionable insights. Integrating AI into clinical practice enhances the
quality of medical care, ultimately improving health outcomes for patients with burns and wounds.
SELF-HEALING BIO-CONCRETE
Self-healing bio-concrete is a type of concrete that incorporates microorganisms, such as
Bacillus fragments, into the mixture and calcium lactate as a nutrient source. The
microorganisms are activated when the concrete cracks, producing calcium carbonate, filling the
cracks, and repairing the concrete. This process is known as bio-mineralization.

The benefits of self-healing bio-concrete include increased durability, reduced maintenance

costs, and improved sustainability, as the concrete can repair itself without human intervention.
Additionally, self-healing bio-concrete is considered environmentally friendly because the
microorganisms used in concrete are naturally occurring and non-toxic.

Self-healing bio-concrete is still a relatively new technology in the research and development
phase. However, initial studies have shown promising results and have demonstrated the
potential for self-healing bio-concrete to be a viable alternative to traditional concrete in specific
applications.

Figure: Self-healing concreates fabrication mechanism.

Self-healing Process: Bacillus bacteria and calcium lactate are mixed with concrete. The
bacterial remains dormant within the concrete. When creak is developed in the concrete the water
and oxygen enter the crack resulting in the activation of bacteria. The activated bacteria produce
calcium carbonate. The calcium carbonate acts as a binder and fills in the cracks, repairing the
concrete and restoring its structural integrity. This process is known as biomineralization.

The Bacillus bacteria used in self-healing bio-concrete are naturally occurring and non-toxic, so
they are considered environmentally friendly. They can also survive in a wide range of
temperatures and pH levels, making them well-suited for use in concrete.
In addition to repairing cracks, self-healing bio-concrete can improve the overall durability of
concrete by reducing the amount of water that can penetrate the surface. This can help to prevent
the development of further cracks and increase the longevity of the concrete.

Importance of Self-Healing Bio-concrete

• Increased durability: Self-healing bio-concrete can repair itself, which can help to
increase its overall durability and reduce the need for maintenance.
• Improved sustainability: Using naturally occurring and non-toxic microorganisms, self-
healing bio- concrete is considered a more environmentally friendly alternative to
traditional concrete.
• Reduced maintenance costs: Because self-healing bio-concrete can repair itself, it can
reduce the need for costly maintenance and repairs over time.
• Increased longevity: By repairing cracks and reducing the amount of water that can
penetrate the surface, self-healing bio-concrete can help extend the lifespan of concrete
structures.
• New applications: The ability of self-healing bio-concrete to repair itself may open up
new applications for concrete that were not possible with traditional concrete.
• Reduced carbon footprint: The biomineralization process used in self-healing bio-
concrete can reduce the carbon footprint associated with concrete production, eliminating
the need for concrete to be transported and replaced when it becomes damaged.
 Bioremediation and Biomining via Microbial Surface Adsorption
(Removal of heavy metals like Lead, Cadmium, Mercury, and Arsenic)

Bioremediation is a powerful tool that employs living organisms to remove or neutralize

pollutants from contaminated environments. It utilizes the remarkable abilities of
microorganisms, plants, or enzymes to degrade or transform harmful substances into less toxic
forms. This process occurs naturally over time, but can also be accelerated by adding specific
microorganisms or other biotic agents. It aims to remove contaminants from the environment and
restore it to a healthy state. On the other hand, biomining refers to using microorganisms to
extract valuable minerals from ore deposits. This process involves using microorganisms to
dissolve minerals from ore, creating a solution that can be separated and purified to obtain
valuable minerals. Biomining is often used to extract metals such as copper, gold, and nickel and
has several advantages over traditional mining methods, including lower energy.

Types of Bioremediations
Microbial Bioremediation: Microorganisms, such as bacteria and fungi, are utilized to break
down pollutants into harmless byproducts. They can degrade hydrocarbons, heavy metals,
pesticides, and various other contaminants.
Phytoremediation: Plants are used to absorb and accumulate pollutants from the soil or water.
They can effectively remove heavy metals and organic compounds through processes like
phytoextraction and phytodegradation.
Enzymatic Bioremediation: Specific enzymes are employed to catalyze the breakdown of
pollutants. Enzymes can be produced by microorganisms or engineered for enhanced efficiency.

Advantages of Bioremediation
Environmentally Friendly: Bioremediation offers a sustainable approach to cleaning up
contaminated sites without causing further harm to the environment.
Cost-Effective: Compared to traditional remediation methods, bioremediation can be more cost-
effective, requiring fewer resources and equipment.
Tailored Solutions: Bioremediation can be customized to target specific contaminants, making
it a versatile tool for diverse pollution scenarios.
 Figure: The contribution of biomining within the circular economy.

Biomining, also known as bioleaching, is a process that employs microorganisms to extract

metals from ore bodies. Traditional mining methods often involve destructive techniques, such
as open-pit mining, which result in significant environmental degradation. Biomining, on the
other hand, offers a more sustainable alternative.

Biomining relies on the metabolic capabilities of microorganisms, such as bacteria and fungi, to
selectively extract target metals from low-grade ores. These microorganisms naturally occur in
ore deposits and possess the ability to oxidize or reduce metals, making them soluble and easier
to extract. Through a series of bioleaching steps, metals like copper, gold, and uranium can be
efficiently recovered. Costs, reduced waste, and increased metal recovery.

Advantages of Biomining
Reduced Environmental Impact: Biomining eliminates the need for harmful chemicals, such
as cyanide and mercury, used in traditional mining. This greatly reduces the risk of water and
soil contamination.
Lower Energy Consumption: Biomining operates at lower temperatures and pressures,
consuming less energy compared to conventional mining methods.
Economically Viable: Biomining allows the extraction of metals from low-grade ores that
would otherwise be economically unviable. This expands the availability of valuable resources.
 Table: Comparing bioremediation via microbial surface adsorption and biomining via
microbial surface adsorption

Aspect Bioremediation Biomining

To remove or neutralize
To extract valuable metals or
Objective pollutants/contaminants from the
minerals from ores.
environment.
Microorganisms adsorb and Microorganisms absorb and extract
Process
degrade pollutants/contaminants, metals from ores.
Targeted Focuses on organic pollutants Focuses on desired metals or
Contaminants/Metals or contaminant minerals.
A diverse range of microbial
Specific microbial strains with metal
Microorganisms strains with pollutant-degrading
adsorption capabilities
capabilities
Can restore ecosystems and Can potentially ecologically issues
Environmental Impact
improve environmental quality cause
Timeframe for It can take months to years Quicker results for metal extraction
Results for significant remediation in controlled conditions
Waste Generation It may generate waste that Waste generation and disposal
and Disposal requires proper disposal considerations in mining operations
Soil, water, and air
Applications Mining operations extraction for metal
pollution remediation

The process of removing polluting heavy metals using bioremediation or

biomining via microbial surface adsorption
• Identification of heavy metal-contaminated sites: Identify the place or area contaminated
with heavy metals, such as soil, water, or industrial waste sites.
• Isolation and characterization of metal-resistant microbial strains: Select and isolate
microbial strains that have demonstrated resistance to heavy metals. These can Include
bacteria, fungi, or archaea.
• Culturing and enrichment of microbial strains: Culture and propagating the selected
microbial strains in a suitable growth medium under laboratory conditions. This step aims to
obtain sufficient active microbial biomass for subsequent applications.
• Preparation of microbial suspension: Harvest the microbial biomass and prepare a
suspension by suspending the biomass in a carrier solution, such as water or nutrient broth.
This suspension will serve as the delivery system for the microbes during application.
• Application of microbial suspension to contaminated sites: Apply microbial suspension to
heavy metal- contaminated areas. Depending on the specific site conditions, this can be done
through spraying, injection, or soil/water mixings.
• Microbial adsorption and sequestration of metal: The applied microbial strains adsorb to
 the surfaces of metal particles or form biofilms. The microbes produce extracellular
compounds such as organic acids or biofilm matrix components with an affinity for binding
metal ions through their metabolic activity.

Table. Examples of different metal-resistant microbes

Heavy Metal Examples of Microbes Used

Pseudomonas sp.: Some strains of Pseudomonas bacteria can tolerate and
accumulate lead.
Bacillus sp.: Certain Bacillus species have been found to exhibit resistance to
Lead
lead and can effectively bind and remove it.
Saccharomyces cerevisiae: This yeast species has been shown to adsorb and
immobilize lead from aqueous solutions.
Cupriavidus metallidurans: This bacterium is known for its high resistance to
heavy metals, including cadmium.
Trichoderma spp.: Some species of Trichoderma fungi have shown the ability
Cadmium
to tolerate and accumulate cadmium.
Chlorella vulgaris: This green microalga has been used for cadmium removal
due to its high metal-binding capacity.
Pseudomonas putida: Certain strains of Pseudomonas putida can tolerate and
accumulate mercury.
Penicillium Chrysogenum: Some strains of Penicillium Chrysogenum fungi
Mercury
have shown the capacity to bind and remove mercury,
Spirogyra sp.: This filamentous green alga has been used for mercury
removal due to its ability to accumulate and sequester mercury.
Shewanella sp.: Certain strains of Shewanella bacteria can tolerate and
accumulate arsenic.
Aspergillus Niger: Some strains of Aspergillus Niger fungi have shown the
Arsenic
capacity to bind and remove arsenic.
Chlorella vulgaris: This green microalga has been used for arsenic removal
due to its ability to accumulate and sequester arsenic.

Methods applied for the Separation or Removal of Metals

Bioleaching, also called biomining or microbial bioleaching is a biotechnological process that
employs microorganisms to extract metal from their ores and the solid metallic waste. The
traditionally used method not being economically feasible in recent days, the bioleaching
method has gained worldwide acceptance. Bioleaching for the extraction of metals uses a
specific group of microorganisms, bacteria or archaebacteria, which interact with the ore-
containing rocks, transforming the solid metal compounds into the extractable forms.

Hydrometallurgy
It is a part of hydrometallurgy, which studies the interactions between organisms and ores to
obtain valuable metals from low-grade ores as a more efficient and sustainable alternative to
conventional extraction methods. The metals mostly extracted with the application of
bioleaching are: Gold, Copper, Silver, Cobalt, Uranium, Zinc, and Nickel.

Microorganisms Involved and Role in Metal Recovery

Bioleaching utilizes certain microorganisms for the extraction of metals from ores. Some of
them are discussed below:

1. Thiobacillus Species
• Thiobacillus ferrooxidans and Thiobacillus thiooxidans are the most active bacteria in
bioleaching.
• These Gram-negative, non-spore-forming rods thrive in highly acidic, aerobic
environments (pH 1.5 to 3).
• They are chemolithoautotrophic, using atmospheric carbon dioxide as a carbon source
and deriving energy from the oxidation of sulfur compounds, including sulfides and
elemental sulfur, which are converted into soluble sulfates.

2. Leptospirillum ferrooxidans
• This acidophilic bacterium oxidizes ferrous iron and is highly tolerant of extreme
conditions, including low pH and high concentrations of metals like uranium,
molybdenum, and silver.
• Although Leptospirillum ferrooxidans cannot oxidize sulfur compounds alone, it works
synergistically with Thiobacillus species to enhance the bioleaching process.

3. Thiobacillus-like and Thermophilic Bacteria

• Thiobacillus-like bacteria, known as Th-bacteria, are moderately thermophilic and grow
on minerals such as pyrite and chalcopyrite at temperatures around 50°C.
• Acidianus brierleyi, an extremely thermophilic archaeon, can thrive at temperatures
above 60°C, growing on ferrous iron and elemental sulfur. It can also reduce sulfur to
hydrogen sulfide under anaerobic conditions.

These microorganisms convert insoluble metal sulfides into water-soluble metal sulfates
through biochemical oxidation, which is crucial for bioleaching.

Figure. Bioleaching
Mechanism of Bioleaching
Bioleaching involves two primary mechanisms:
• Direct Bacterial Leaching
• Indirect Bacterial Leaching

1. Direct Bacterial Leaching (Contact leaching)

• In direct bacterial leaching, microorganisms directly interact with the mineral surface.
• Here, the physical contact between bacterial cells and the mineral sulfide surface
occurs.
• Organisms such as Thiobacillus ferrooxidans, catalyze the oxidation of minerals
through a series of enzymatic reactions.
• The bacteria tend to attach to specific sites on the mineral surface, often where there are
imperfections in the crystal structure.

For example, pyrite (FeS₂) is oxidized to ferric (III) sulfate via the following reaction:

2FeS2 + 7O2 + 7H 2O → 2FeSO4 + 2H2SO4

Direct oxidation can also be applicable for other non-iron metal sulfides such as covellite
(CuS), chalcocite (Cu₂S), and sphalerite (ZnS).

Figure. Type and mechanism of bioleaching

 2. Indirect Bacterial Leaching (Non- contact leaching)
• In Indirect bacterial leaching, no direct contact between the microorganisms and the
minerals occurs.
• Here, the strong oxidizing agents produced by bacteria, such as ferric ions and sulfuric
acids
• Instead, bacteria produce strong oxidizing agents, such as ferric ions and sulfuric acid,
which chemically oxidize the metal sulfides in the ore.

In the bioleaching of uranium, the following reaction occurs:

U2O + Fe2 (SO4)3 → UO2SO4 + 2FeSO4

In this mechanism, ferric iron is generated in an acidic environment (pH < 5.0) and acts as a
lixiviant, oxidizing the sulfide minerals. The ferrous iron produced in this reaction can be
reoxidized to ferric iron by T. ferrooxidans or L. ferrooxidans, thus perpetuating the leaching
process. The presence of Thiobacillus thiooxidans further accelerates the oxidation of sulfur to
sulfuric acid, creating a favorable acidic environment for continued metal solubilization.

In practice, both direct and indirect leaching mechanisms often occur simultaneously,
particularly in natural environments and industrial applications.

Differences between direct bioleaching and indirect bioleaching

Character Direct Bioleaching Indirect bioleaching

Microorganisms directly interact

with the mineral substrate where Microorganisms generate highly effective
Mechanism
their enzymatic activity catalyzes the oxidizing agents that oxidize metal sulfides.
oxidation of metal

For example, an organism oxidizes ferrous

Microbial Organism directly attaches to metal
to ferric ions, which reacts with the metal
action sulfide ores
sulfides

Reaction 2FeS2+7O2+2H2O→2FeSO4 + 2H2

FeS2+14Fe3++8H2O→15Fe2++2SO42−+16H+
(Example) SO4

Used in direct extraction of metals

Application Used in large scale, such as heap leaching.
from sulfide ores.

Types of Bioleaching
Three major processes are prevalent in bioleaching.
1. Slope Leaching
• In slope leaching, fine ore is ground and placed in a large, slope-shaped dump.
 • The process involves continuously sprinkling water containing Thiobacillus bacteria
over the ore.
• As the solution trickles down through the ore, it gathers at the bottom, rich with
dissolved metals.
• This metal-rich solution is then collected and processed further to recover the metals
and regenerate the bacterial culture in an oxidation pond.

2. Heap Leaching
• Heap leaching is similar to slope leaching but involves the ore being arranged in large
heaps, known as leach heaps.
• An aqueous solution containing Thiobacillus is sprayed over these heaps. The solution
percolates through the heap, dissolving metals as it goes.
• The metal-laden solution is collected at the heap’s base and then processed to extract
the metals and sustain the bacterial culture in an oxidation pond.

3. In-situ Leaching
• In-situ leaching does not require the ore to be removed from its natural location.
Instead, after surface blasting to increase permeability, water containing Thiobacillus is
pumped through drilled passageways within the ore body.
• The solution slowly seeps through the rock, dissolving the metals. The metal-rich
solution is then collected from the base of the ore body, and the water is reused after the
bacterial culture has been regenerated.

Metal-Specific Bioleaching Processes

Copper Leaching
• Copper is extracted from ores such as chalcocite (Cu₂S), chalcopyrite (CuFeS₂), and
covellite (CuS) using both heap leaching and in-situ leaching processes.
• Dilute sulfuric acid is percolated through the ore piles, dissolving the copper into the
solution. The liquid collected from the base of the pile is rich in copper and is
transported to a precipitation plant, where the metal is purified and precipitated.

Uranium Leaching
• Uranium extraction is primarily an indirect bioleaching process.
• Insoluble tetravalent uranium is oxidized with a hot H₂SO₄/FeSO₄ solution, converting
it into a soluble hexavalent uranium sulfate.
• The bacteria, particularly T. ferrooxidans, do not directly attack the uranium ore but
instead assist in the production of ferric iron (Fe³⁺), which acts as an oxidant.
• The process is optimized at a pH of 1.5-3.5 and a temperature of around 35°C.

Gold and Silver Leaching

• The bioleaching of gold and silver involves the microbial breakdown of refractory ores,
such as arsenopyrite and pyrite, to enhance metal recovery.
• Gold is typically extracted from arsenopyrite or pyrite, while silver is more readily
 solubilized during the microbial leaching of iron sulfides.
• This process is particularly promising for recovering precious metals from low-grade
ores.

Factors Affecting Bioleaching

1. Choice of Bacteria
• The bacteria must survive and thrive under extreme conditions such as high
temperatures, acidic environments, and elevated concentrations of heavy metals. Their
efficiency directly impacts the bioleaching process. Most used microorganisms are
chemolithotrophic acidophiles. It also employs fungi and some cyanogenic bacteria.
E.g. Acidithiobacillus ferrooxidans, and Acidithiobacillus thiooxidans.
• Fungal bioleaching is done using Aspergillus niger and Penicillium simplicissium

2. pH and Temperature
• Optimal pH (around 2.0–2.5) and temperature (28–30°C) are crucial for maximizing
microbial activity and metal solubilization. Since acidophilic chemolithotrophs are used
for the bioleaching process, an acidic environment (low pH) is required. Deviations
from these conditions can inhibit bacterial growth and decrease metal extraction rates.

3. Population Density of Microorganisms

• The higher the bacterial population densities, the higher the leaching rate due to an
increased number of microorganisms accelerating oxidation reactions.

4. Metal Tolerance of Microorganisms

• The leaching process often leads to high metal concentrations in the leachate.
• Organisms with high tolerance to increased metal concentration are effective, as
elevated metal concentration can be toxic to most bacteria.
• The use of tolerant/resistant organisms avoids inhibition and ensures effective metal
extraction. Bacteria, particularly, thiobacilli tolerate high levels of heavy metals and can
be used as best option.

5. Oxidation Reactions and Compositions

• Effective bioleaching requires maintaining appropriate levels of oxidation reactions to
keep ferric ions and metals in solution. Low oxidation levels are necessary for
achieving the fastest leaching rates.

6. Surface Area of the Ore/ Particle size

• The higher the surface area (lesser ore particle size) of the ore, the higher the bacterial
oxidation due to increased area for bacterial action
• An optimal particle size of about 42 µm is often used to maximise leaching efficiency.

7. Nutrients
• Chemolithoautotrophic bacteria require only inorganic compounds for growth. They
 require inorganic compounds such as iron and sulfur to promote their growth. Essential
nutrients such as iron, sulfur, ammonium, phosphate, and magnesium salts must be
provided to support bacterial activity and metal extraction.

8. Oxygen and Carbon Dioxide

• Oxygen: An adequate oxygen supply (1.5-4mg/l dissolved oxygen) is crucial for high
bacterial activity.
• Carbon dioxide: CO2 is the sole carbon source required for bioleaching.

9. Mineral Substrate
• Leaching efficacy is affected by mineral constituents.
• High carbonate content can increase pH and inhibit bacterial activity, requiring acid
addition to maintain low pH.

10. Surfactants and Organic Extractants

• Surfactants and organic compounds used in solvent extraction can inhibit bacterial
activity by decreasing surface tension and reducing oxygen transfer.
• Solvent extraction must be managed to avoid adverse effects on the bioleaching
process.

11. Catalyst
• The addition of catalysts like silver ions (Ag+), graphene, and biochar can significantly
enhance bioleaching performance.

Applications of Bioleaching
• Environmental Stabilization: Bioleaching stabilizes sulfate toxins, minimizing
environmental impact.
• Emission Reduction: It eliminates harmful sulfur dioxide emissions associated with
traditional smelting, improving health and environmental outcomes.
• Cost-Effective Extraction: Bioleaching is a more cost-efficient method compared to
smelting, particularly for low-grade ores.
• Optimized Recovery Processes: It allows for two-phase optimization, involving initial
characterization and microorganism acclimatization, followed by scaling up to
intermediate bioleaching techniques using bioreactors or columns.